← Open Payments lookup

ROBERT WEBB: Open Payments

NPI 1154412385 · LAS VEGAS, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$625 in 29 payments from 9 companies in 2025. Trend: 2023 $680 · 2024 $530 · 2025 $625

Food & beverage: $605Education: $20
CompanyPaymentsAmount
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)14$295
Vanda Pharmaceuticals Inc.2$72
Novo Nordisk Inc2$52
ABBVIE INC.3$47
AstraZeneca Pharmaceuticals LP2$42
Bayer Healthcare Pharmaceuticals Inc.2$34
Salix Pharmaceuticals, a division of Bausch Health US, LLC2$33
Forte Bio-Pharma LLC1$27
Lilly USA, LLC1$22

Products named: CAPLYTA, FANAPT, Kerendia, XIFAXAN, QULIPTA, Ozempic, PROLATE, BREZTRI.

Industry payments across NV — which companies pay providers there.